To buy or not to buy is the question for many companies acquiring assets for their business. Equipment and other assets are extremely important when a company is trying to get off the ground in a new business. The chief executive officer would have to ask how would we finance the equipment needed, pay back investors, and make the company profitable for all. This new biotech company is seeking financial remedies in becoming a profitable company. Bonnesante` Research Company has 30 employees and located in Irvine, California. They operate on venture capital funding now, which are investors that are offered a stake in a company that has risk of failing or being very profitable. Acquisitions are Bonnesante` major focus area as the company 's operations start to gather pace. The company has to decide whether to lease or buy equipment to achieve their goal to stay in the positive. In 2xx1, Bonnesante` Research Company future hinged on summiting the development of an anti-infective drug to the Food and Drug Administration. In 2xx4, the company was making a profit therefore; they required an advanced digital spectrometer to achieve key breakthroughs in their research and development department. They company was doing so good that in 2xx7 Bonnesante` Research Company plan to transform the company into a fully integrated pharmaceutical company with its own marketing and manufacturing operations. With the help of key players like Samuel Malone the chief executive officer, Nicholas Tortelli the chief operating officer, and. Ana Machuca and Consultant. In 2xx1, Bonnesante` required a mainframe computer in their research and development department, so that they would have the ability to run advance analytical software. Their first drug needs to pass trials for the Food and Drug Administration so a mainframe to run the analytical software. They have found a mainframe computer that has both lease and buy options but they
To buy or not to buy is the question for many companies acquiring assets for their business. Equipment and other assets are extremely important when a company is trying to get off the ground in a new business. The chief executive officer would have to ask how would we finance the equipment needed, pay back investors, and make the company profitable for all. This new biotech company is seeking financial remedies in becoming a profitable company. Bonnesante` Research Company has 30 employees and located in Irvine, California. They operate on venture capital funding now, which are investors that are offered a stake in a company that has risk of failing or being very profitable. Acquisitions are Bonnesante` major focus area as the company 's operations start to gather pace. The company has to decide whether to lease or buy equipment to achieve their goal to stay in the positive. In 2xx1, Bonnesante` Research Company future hinged on summiting the development of an anti-infective drug to the Food and Drug Administration. In 2xx4, the company was making a profit therefore; they required an advanced digital spectrometer to achieve key breakthroughs in their research and development department. They company was doing so good that in 2xx7 Bonnesante` Research Company plan to transform the company into a fully integrated pharmaceutical company with its own marketing and manufacturing operations. With the help of key players like Samuel Malone the chief executive officer, Nicholas Tortelli the chief operating officer, and. Ana Machuca and Consultant. In 2xx1, Bonnesante` required a mainframe computer in their research and development department, so that they would have the ability to run advance analytical software. Their first drug needs to pass trials for the Food and Drug Administration so a mainframe to run the analytical software. They have found a mainframe computer that has both lease and buy options but they